| Cancer SLC43A2 alters T cell methionine metabolism and histone methylation Y Bian, W Li, DM Kremer, P Sajjakulnukit, S Li, J Crespo, ZC Nwosu, ... Nature 585 (7824), 277-282, 2020 | 436 | 2020 |
| Fucoidan structure and activity in relation to anti-cancer mechanisms G Van Weelden, M Bobiński, K Okła, WJ Van Weelden, A Romano, ... Marine drugs 17 (1), 32, 2019 | 311 | 2019 |
| Tissue-resident memory T cells in tumor immunity and immunotherapy K Okła, DL Farber, W Zou Journal of Experimental Medicine 218 (4), 2021 | 157 | 2021 |
| Histone deacetylase inhibitors and phenotypical transformation of cancer cells A Wawruszak, J Kalafut, E Okon, J Czapinski, M Halasa, ... Cancers 11 (2), 148, 2019 | 96 | 2019 |
| Clinical relevance and immunosuppressive pattern of circulating and infiltrating subsets of myeloid-derived suppressor cells (MDSCs) in epithelial ovarian cancer K Okła, A Czerwonka, A Wawruszak, M Bobiński, M Bilska, R Tarkowski, ... Frontiers in Immunology 10, 691, 2019 | 85 | 2019 |
| Anticancer effect of ethanol Lycium barbarum (Goji berry) extract on human breast cancer T47D cell line A Wawruszak, A Czerwonka, K Okła, W Rzeski Natural product research 30 (17), 1993-1996, 2016 | 69 | 2016 |
| Immunotherapies based on PD-1/PD-L1 pathway inhibitors in ovarian cancer treatment A Pawłowska, D Suszczyk, K Okła, B Barczyński, J Kotarski, I Wertel Clinical & Experimental Immunology 195 (3), 334-344, 2019 | 42 | 2019 |
| Tumor-associated macrophages and myeloid-derived suppressor cells as immunosuppressive mechanism in ovarian cancer patients: progress and challenges K Okła, I Wertel, G Polak, J Surówka, A Wawruszak, J Kotarski International Reviews of Immunology 35 (5), 372-385, 2016 | 33 | 2016 |
| Accumulation of blood-circulating PD-L1-expressing M-MDSCs and monocytes/macrophages in pretreatment ovarian cancer patients is associated with soluble PD-L1 K Okła, A Rajtak, A Czerwonka, M Bobiński, A Wawruszak, R Tarkowski, ... Journal of Translational Medicine 18, 1-17, 2020 | 31 | 2020 |
| Integration of local and systemic immunity in ovarian cancer: Implications for immunotherapy A Rajtak, M Ostrowska-Leśko, K Żak, R Tarkowski, J Kotarski, K Okła Frontiers in Immunology 13, 1018256, 2022 | 22 | 2022 |
| Histone deacetylase inhibitors reinforce the phenotypical markers of breast epithelial or mesenchymal cancer cells but inhibit their migratory properties A Wawruszak, E Gumbarewicz, E Okon, W Jeleniewicz, J Czapinski, ... Cancer Management and Research, 8345-8358, 2019 | 22 | 2019 |
| Additive pharmacological interaction between cisplatin (CDDP) and histone deacetylase inhibitors (HDIs) in MDA-MB-231 triple negative breast cancer (TNBC) cells with altered … A Wawruszak, JJ Luszczki, J Kalafut, K Okla, M Halasa, A Rivero-Muller, ... International Journal of Molecular Sciences 20 (15), 3663, 2019 | 22 | 2019 |
| Assessment of the clinicopathological relevance of mesothelin level in plasma, peritoneal fluid, and tumor tissue of epithelial ovarian cancer patients K Okła, J Surówka, K Frąszczak, A Czerwonka, K Kaławaj, A Wawruszak, ... Tumor Biology 40 (10), 1010428318804937, 2018 | 21 | 2018 |
| Bobi nski K Okła, A Czerwonka, A Wawruszak M, 0 | 19 | |
| The effect of fucoidan, a potential new, natural, anti-neoplastic agent on uterine sarcomas and carcinosarcoma cell lines: ENITEC collaborative study M Bobiński, K Okła, W Bednarek, A Wawruszak, ... Archivum Immunologiae et Therapiae Experimentalis 67, 125-131, 2019 | 17 | 2019 |
| Blood-based analyses of cancer: Circulating myeloid-derived suppressor cells–is a new era coming? K Okla, I Wertel, A Wawruszak, M Bobiński, J Kotarski Critical Reviews in Clinical Laboratory Sciences 55 (6), 376-407, 2018 | 17 | 2018 |
| Gemcitabine and selected mTOR inhibitors in uterine sarcomas and carcinosarcoma cells-an isobolographic analysis M Bobiński, K Okła, J Łuszczki, W Bednarek, A Wawruszak, ... International Journal of Medical Sciences 17 (18), 2987, 2020 | 11 | 2020 |
| Influence of ovarian cancer type I and type II microenvironment on the phenotype and function of monocyte-derived dendritic cells J Surówka, I Wertel, K Okła, W Bednarek, R Tarkowski, J Kotarski Clinical and Translational Oncology 19, 1489-1497, 2017 | 11 | 2017 |
| Isobolographic analysis demonstrates the additive and synergistic effects of gemcitabine combined with fucoidan in uterine sarcomas and carcinosarcoma cells M Bobiński, K Okła, J Łuszczki, W Bednarek, A Wawruszak, ... Cancers 12 (1), 107, 2019 | 9 | 2019 |
| Myeloid-Derived Suppressor Cells (MDSCs) in Ovarian Cancer—Looking Back and Forward K Okła Cells 12 (14), 1912, 2023 | 8 | 2023 |
Andrzej StepulakHead of the Dept. of Biochemistry and Molecular Biology, Medical University in Lublin, PolandEmail được xác minh tại umlub.pl